Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott Berry

Showing results (81-90 of 146) with videos related to

Pageof 15
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 27, 2011
Randomized phase II trial of Custirsen (OGX-011) in combination with docetaxel or mitoxantrone as second-line therapy in patients with metastatic castrate-resistant prostate cancer progressing after first-line docetaxel: CUOG trial P-06cFred Saad, Sebastien Hotte, Scott North, et al.
Elife|July 19, 2023
Integrating analog and digital modes of gene expression at <i>Arabidopsis FLC</i>Rea L Antoniou-Kourounioti, Anis Meschichi, Svenja Reeck, et al.
Trials|July 5, 2022
Correction: Prophylaxis in healthcare workers during a pandemic: a model for a multi-centre international randomised controlled trial using Bayesian analysesPepa Bruce, Kate Ainscough, Lee Hatter, et al.
Trials|June 27, 2022
Prophylaxis in healthcare workers during a pandemic: a model for a multi-centre international randomised controlled trial using Bayesian analysesPepa Bruce, Kate Ainscough, Lee Hatter, et al.
Stroke|July 4, 2015
Adopting a Patient-Centered Approach to Primary Outcome Analysis of Acute Stroke Trials Using a Utility-Weighted Modified Rankin ScaleNapasri Chaisinanunkul, Opeolu Adeoye, Roger J Lewis, et al.
Pharmacological Reports : PR|May 17, 2023
Correction: A role for macrophages under cytokine control in mediating resistance to ADI-PEG20 (pegargiminase) in ASS1-deficient mesotheliomaMelissa M Phillips, Iuliia Pavlyk, Michael Allen, et al.
ACS ES&T Water|August 8, 2023
Development and Validation of a Simplified Method for Analysis of SARS-CoV-2 RNA in University DormitoriesWilliam Strike, Atena Amirsoleimani, Abisola Olaleye, et al.
Pharmacological Reports : PR|April 3, 2023
A role for macrophages under cytokine control in mediating resistance to ADI-PEG20 (pegargiminase) in ASS1-deficient mesotheliomaMelissa M Phillips, Iuliia Pavlyk, Michael Allen, et al.
Annals of Emergency Medicine|March 20, 2012
An overview of the adaptive designs accelerating promising trials into treatments (ADAPT-IT) projectWilliam J Meurer, Roger J Lewis, Danilo Tagle, et al.
Current Oncology (Toronto, Ont.)|September 27, 2023
Report from the 24th Annual Western Canadian Gastrointestinal Cancer Consensus Conference on Colorectal Cancer, Richmond, British Columbia, 28-29, October 2022Sharlene Gill, Shahid Ahmed, Brady Anderson, et al.
Pageof 15

Showing results (81-90 of 146) with videos related to

Sort By:
Pageof 15
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 27, 2011
Randomized phase II trial of Custirsen (OGX-011) in combination with docetaxel or mitoxantrone as second-line therapy in patients with metastatic castrate-resistant prostate cancer progressing after first-line docetaxel: CUOG trial P-06cFred Saad, Sebastien Hotte, Scott North, et al.
Elife|July 19, 2023
Integrating analog and digital modes of gene expression at <i>Arabidopsis FLC</i>Rea L Antoniou-Kourounioti, Anis Meschichi, Svenja Reeck, et al.
Trials|July 5, 2022
Correction: Prophylaxis in healthcare workers during a pandemic: a model for a multi-centre international randomised controlled trial using Bayesian analysesPepa Bruce, Kate Ainscough, Lee Hatter, et al.
Trials|June 27, 2022
Prophylaxis in healthcare workers during a pandemic: a model for a multi-centre international randomised controlled trial using Bayesian analysesPepa Bruce, Kate Ainscough, Lee Hatter, et al.
Stroke|July 4, 2015
Adopting a Patient-Centered Approach to Primary Outcome Analysis of Acute Stroke Trials Using a Utility-Weighted Modified Rankin ScaleNapasri Chaisinanunkul, Opeolu Adeoye, Roger J Lewis, et al.
Pharmacological Reports : PR|May 17, 2023
Correction: A role for macrophages under cytokine control in mediating resistance to ADI-PEG20 (pegargiminase) in ASS1-deficient mesotheliomaMelissa M Phillips, Iuliia Pavlyk, Michael Allen, et al.
ACS ES&T Water|August 8, 2023
Development and Validation of a Simplified Method for Analysis of SARS-CoV-2 RNA in University DormitoriesWilliam Strike, Atena Amirsoleimani, Abisola Olaleye, et al.
Pharmacological Reports : PR|April 3, 2023
A role for macrophages under cytokine control in mediating resistance to ADI-PEG20 (pegargiminase) in ASS1-deficient mesotheliomaMelissa M Phillips, Iuliia Pavlyk, Michael Allen, et al.
Annals of Emergency Medicine|March 20, 2012
An overview of the adaptive designs accelerating promising trials into treatments (ADAPT-IT) projectWilliam J Meurer, Roger J Lewis, Danilo Tagle, et al.
Current Oncology (Toronto, Ont.)|September 27, 2023
Report from the 24th Annual Western Canadian Gastrointestinal Cancer Consensus Conference on Colorectal Cancer, Richmond, British Columbia, 28-29, October 2022Sharlene Gill, Shahid Ahmed, Brady Anderson, et al.
Pageof 15